Compare Kidswell Bio Corp. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 2.20%
- The company has been able to generate a Return on Capital Employed (avg) of 2.20% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -34.17
3
Poor long term growth as Operating profit has grown by an annual rate 17.97% of over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
5
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
JPY 7,196 Million (Micro Cap)
193.00
NA
0.00%
-0.45
-23.40%
4.35
Revenue and Profits:
Net Sales:
1,270 Million
(Quarterly Results - Jun 2026)
Net Profit:
198 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.76%
0%
25.76%
6 Months
-35.41%
0%
-35.41%
1 Year
-38.75%
0%
-38.75%
2 Years
31.75%
0%
31.75%
3 Years
-1.78%
0%
-1.78%
4 Years
-31.69%
0%
-31.69%
5 Years
-74.58%
0%
-74.58%
Kidswell Bio Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
45.98%
EBIT Growth (5y)
17.97%
EBIT to Interest (avg)
-20.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
1.32
Tax Ratio
2.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.20%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
193
Industry P/E
Price to Book Value
3.40
EV to EBIT
21.57
EV to EBITDA
21.52
EV to Capital Employed
7.04
EV to Sales
0.76
PEG Ratio
1.87
Dividend Yield
NA
ROCE (Latest)
32.61%
ROE (Latest)
1.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
1,269.50
1,571.10
-19.20%
Operating Profit (PBDIT) excl Other Income
216.50
-222.50
197.30%
Interest
23.10
21.10
9.48%
Exceptional Items
32.70
-37.60
186.97%
Consolidate Net Profit
197.90
-271.20
172.97%
Operating Profit Margin (Excl OI)
170.50%
-141.70%
31.22%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is -19.20% vs -9.84% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 172.97% vs -33.33% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
6,589.90
5,082.10
29.67%
Operating Profit (PBDIT) excl Other Income
-138.30
28.80
-580.21%
Interest
49.10
42.50
15.53%
Exceptional Items
-27.00
1.40
-2,028.57%
Consolidate Net Profit
-414.00
-21.10
-1,862.09%
Operating Profit Margin (Excl OI)
-21.00%
5.50%
-2.65%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 29.67% vs 109.04% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -1,862.09% vs 98.52% in Mar 2025
About Kidswell Bio Corp. 
Kidswell Bio Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






